DIMENSIONAL FUND ADVISORS LP
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 354204
AUSTIN, TX
Position in XERS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,503,220
+$8,393,730 QoQ
Shares Held
1,073,639
+2106.3% QoQ
Ownership
0.589%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 238 holders
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 90%
Shared 2%
None 8%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $3,170,376,127 across 48 Drug Manufacturers - Specialty & Generic names. XERS ranks #31 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
25,417,271 | $625,519,037 | |
| 2 | VTRS |
Viatris Inc
|
29,970,094 | $475,925,092 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
527,904 | $286,034,221 | |
| 4 | ALKS |
Alkermes plc.
|
4,194,873 | $219,811,343 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
1,466,260 | $162,666,882 | |
| 6 | ZTS |
Zoetis Inc.
|
2,173,278 | $156,171,754 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
2,661,291 | $125,799,224 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
732,877 | $123,519,088 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,503,220 | 1,073,639 | Shares | Sole | 2026-08-11 | |
| 2024-06-30 | $109,490 | 48,663 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $121,768 | 55,100 | Shares | Sole | 2024-05-10 | |
| 2022-06-30 | $69,426 | 45,082 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $100,848 | 39,394 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $204,724 | 69,872 | Shares | Defined | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||